Catalio Capital Management, LP
Holdings as of 2025-12-31, filed 2026-09-02
This is history, not a current position. These holdings describe 2025-12-31, and the report became public 245 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
45
Value reported by manager
$565.8M
Sum of our stored positions
$565.8M
should match the line above
Disclosure lag
245 d
quarter end to filing
Top 5 concentration
29.0%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
45 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| GILEAD SCIENCES INC | COM | $35.5M | 289,312 | — | 375558103 |
| BRISTOL-MYERS SQUIBB CO | COM | $34.9M | 647,899 | — | 110122108 |
| BOSTON SCIENTIFIC CORP | COM | $34.4M | 360,428 | — | 101137107 |
| BRIDGEBIO PHARMA INC | COM | $31.4M | 410,700 | — | 10806X102 |
| ELI LILLY & CO | COM | $27.9M | 25,923 | — | 532457108 |
| DIANTHUS THERAPEUTICS INC | COM | $26.9M | 653,572 | — | 252828108 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $25.4M | 119,265 | — | 04351P101 |
| SYNDAX PHARMACEUTICALS INC | COM | $25.1M | 1,196,807 | — | 87164F105 |
| JOHNSON & JOHNSON | COM | $25M | 120,840 | — | 478160104 |
| REGENERON PHARMACEUTICALS | COM | $23M | 29,797 | — | 75886F107 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $17.6M | 252,901 | — | 86366E106 |
| SOLENO THERAPEUTICS INC | COM | $16.7M | 360,340 | — | 834203309 |
| CYTOKINETICS INC | COM NEW | $16.4M | 258,381 | — | 23282W605 |
| EDWARDS LIFESCIENCES CORP | COM | $15.9M | 187,048 | — | 28176E108 |
| INTUITIVE SURGICAL INC | COM NEW | $15.4M | 27,209 | — | 46120E602 |
| NATERA INC | COM | $14.3M | 62,273 | — | 632307104 |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | $13.3M | 821,195 | — | 00650F109 |
| ABIVAX SA | SPONSORED ADS | $13.3M | 98,514 | — | 00370M103 |
| SUPERNUS PHARMACEUTICALS INC | COM | $12.8M | 257,465 | — | 868459108 |
| FRACTYL HEALTH INC | COM | $12.1M | 5,491,866 | — | 35168W103 |
| MINERALYS THERAPEUTICS INC | COM | $12M | 331,849 | — | 603170101 |
| PHATHOM PHARMACEUTICALS INC | COM | $11.6M | 698,996 | — | 71722W107 |
| ADMA BIOLOGICS INC | COM | $10.3M | 564,461 | — | 000899104 |
| ARCELLX INC | COMMON STOCK | $10.2M | 156,109 | — | 03940C100 |
| DYNE THERAPEUTICS INC | COM | $10.2M | 519,715 | — | 26818M108 |
| DISC MEDICINE INC | COM | $8.8M | 110,427 | — | 254604101 |
| OCULAR THERAPEUTIX INC | COM | $8.7M | 714,501 | — | 67576A100 |
| SEPTERNA INC | COM | $8.2M | 294,360 | — | 81734D104 |
| PROTARA THERAPEUTICS INC | COM STK | $7.7M | 1,446,254 | — | 74365U107 |
| UNIQURE NV | SHS | $6.9M | 288,345 | — | N90064101 |
| OLEMA PHARMACEUTICALS INC | COM | $6.7M | 267,058 | — | 68062P106 |
| TERNS PHARMACEUTICALS INC | COM | $5.5M | 136,958 | — | 880881107 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $3.7M | 162,550 | — | 90400D108 |
| HEARTFLOW INC | COM | $3.3M | 113,857 | — | 42238D107 |
| GRAIL INC | COM | $2.6M | 30,313 | — | 384747101 |
| FULCRUM THERAPEUTICS INC | COM | $2.3M | 201,301 | — | 359616109 |
| BILLIONTOONE INC | CL A | $2.1M | 25,505 | — | 090168105 |
| ELEDON PHARMACEUTICALS INC | COM | $1.9M | 1,259,820 | — | 28617K101 |
| HYPERFINE INC | COM CL A | $1.3M | 1,320,041 | — | 44916K106 |
| PALVELLA THERAPEUTICS INC NE | COM | $1.1M | 10,452 | — | 697947109 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $1.1M | 142,984 | — | 48576U205 |
| METAGENOMI INC | COM | $857K | 528,993 | — | 59102M104 |
| ATAI BECKLEY NV | SHS | $805.1K | 196,858 | — | N0731H103 |
| OUTSET MED INC | COM NEW | $438.8K | 118,279 | — | 690145206 |
| SENSEI BIOTHERAPEUTICS INC | COM NEW | $157K | 14,718 | — | 81728A207 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-09-02